Delivery Order SPE2DB22D3301-SPE2DB26FX4FE
Award Date 11/3/25
Potential Completion Date 11/4/25
Potential Value $1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,536.80 to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml in 100 ml bottles, with an ultimate completion date of September 10, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The pharmaceutical product will be performed at the vendor's Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 5, 2025, for the supply of Visipaque 270 mg/ml in 150 ml bottles, valued at $1,599.09 with a firm fixed price arrangement. The contract requires completion by September 8, 2025, and represents a non-set-aside award issued through open competition. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.99...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Visipaque 320 mg/ml infusion bottles (150 ml units) with a ceiling value of $4,126.40. This firm fixed-price delivery order, which is expected to be completed by August 20, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.9 billion through December 2026. The award was...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $16,296.38 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/ml in 100ml bottles. This competitively awarded, firm fixed price contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025, and represents a non-set-aside procurement. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $2,503.35 delivery order to AmerisourceBergen Drug Corp on October 14, 2025, for the supply of Visipaque 320 mg/ml in 100ml bottles, a contrast medium used in medical imaging procedures. This firm fixed-price delivery order, which represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX valued at $999,999,999.00 through December 2026), carries no set-aside designation and is scheduled...
- The Defense Logistics Agency awarded a delivery order valued at $11,396.08 to AmerisourceBergen Drug Corp for the supply of Visipaque 320 mg/mL in 100 mL bottles. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location. Visipaque is a contrast medium used in medical imaging procedures, reflecting the critical role of...
- The Defense Logistics Agency awarded a $1,650.56 delivery order to AmerisourceBergen Drug Corp for Visipaque 320 mg/ml infusion bottles (150 ml) on September 25, 2025, with completion scheduled for September 26, 2025. This is a firm fixed price delivery order with no set-aside designation, issued under open competition. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under the vendor's larger...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a $10,053.00 firm fixed-price delivery order by the Defense Logistics Agency on June 17, 2025, for the supply of Visipaque 320 mg/ml in 100ml bottles. The contract is a non-set-aside competitive award with an ultimate completion date of June 18, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This $999,999,999.00 prime...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Visipaque 320 mg/ml, a pharmaceutical product, with a ceiling value of $26,715.17 and a period of performance through July 3, 2025. The contract is a firm-fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award, valued at $4,169.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Visipaque 320 mg/ml infusion bottles, a specialty pharmaceutical product. The contract is a delivery order with a firm fixed price and has an ultimate completion date of November 17, 2023. The award was made on November 16, 2023. There is no set-aside designation...